Inflammatory Rheumatic Disorders

Disease State Hub

Videos

Expert Conversations on Trials in Rheumatology: IL-6 and Beyond

02/08/2021

In this video, Leonard Calabrese, DO, and Cassandra Calabrese, DO, discuss their experiences with the COVID-19 pandemic, including the ongoing drug trials at the Cleveland Clinic.

02/08/2021

Research Summaries

FDA ALERT

FDA Approves First Biosimilar to Tocilizumab to Treat Adults, Pediatric Patients With Arthritis

11/15/2023

Jessica Ganga

In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.

11/15/2023

research summary

research summary

Efficacy, Safety of Risankizumab for Treatment of Active Psoriatic Arthritis

06/21/2023

Leigh Precopio

Researchers examined the efficacy and safety of a humanized monoclonal antibody for the treatment of active psoriatic arthritis in some patient populations.

06/21/2023

Research Summary

Inflammation Reduction Medications May Lower Dementia Risk in Patients With Rheumatoid Arthritis

02/27/2023

Researchers examined the association between inflammation-reducing medications and dementia risk in patients with rheumatoid arthritis.

02/27/2023

Health Outcomes

Study Reveals the Symptoms That Patients With RMDs Prioritize

02/17/2021

A new app allows patients with rheumatic and musculoskeletal diseases to choose which measures of disease activity to track—and the results can help direct personalized treatment.

02/17/2021

Diagnosis

Updated ACR/EULAR Criteria May Classify SLE Earlier

07/01/2020

The ACR and EULAR updated their criteria for classifying systemic lupus erythematosus in 2019. How did the newer criteria perform compared with earlier systems of classification? Read more to find out. ...

07/01/2020

October 2024

Current Issue

October 2024

Volume 64

Issue 9